AI-driven dermatology platform Cureskin has netted $20 million in a Sequence B funding spherical led by HealthQuad. The spherical was additionally participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.
“These funds will assist additional improve our AI capabilities, speed up our progress, and increase resolution choices,” mentioned co-founder and CEO Guna Kakulapati in an announcement.
Cureskin beforehand raised $5 million in Sequence A funding. To this point, it claims to have handled about 1.5 million clients for numerous pores and skin situations via its app. It notes that over 80% of them are from tier 2 and three cities.Â
Diabetes-focused well being tech startup Sugar.match has obtained a further $5 million in Sequence A funding from B Capital.Â
This brings its complete Sequence A funding, the primary spherical of which occurred in November, to $16 million.Â
In an announcement, the corporate mentioned it’s going to use its further funds to increase its choices, enhance its presence, and hasten R&D in diabetes administration.Â
Since launching by end-2021, Sugar.match has now served over 30,000 customers on its platform, providing a personalised, complete program for managing diabetes that leverages steady glucose monitoring expertise and information. It has additionally lately began working diabetes clinics in Bangalore, which provide a spread of companies reminiscent of stress therapies, stay health and yoga classes, and VR chromotherapy.Â
Diagnostic service supplier Cardiotrack, a model of Uber Diagnostics, has obtained $2 million in a pre-Sequence A funding spherical led by Girish Narasimhan, angel investor and principal of a global funding banking agency.Â
This provides to the $1.6 million it raised beforehand from a cohort of high-net-worth people. It has not disclosed the place and the way it will use its contemporary funds.
Cardiotrack, which provides telemedicine kits, medical-grade and IoT diagnostic gadgets, and information analytics options, serves a few of India’s largest well being and life insurers and community of diagnostic centres in over 300 areas.